Full Text View
Tabular View
No Study Results Posted
Related Studies
Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients
This study is ongoing, but not recruiting participants.
Study NCT01516814   Information provided by Bayer

First Received on January 20, 2012.   Last Updated on March 6, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pulmonary Embolism
Additional conditions recognized in this trial
Embolism
Venous Thromboembolism
Venous Thrombosis
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Lung Diseases
Respiratory Tract Diseases
Thromboembolism
Thrombosis
Vascular Diseases
Interventions listed in this trial
Rivaroxaban (Xarelto, BAY59-7939)
Unfractionated heparin
Warfarin
Additional drug interventions recognized in this trial
Calcium heparin
Heparin
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services